Загрузка...
MiR-192靶向负调控Bim表达诱导肺癌顺铂耐药
BACKGROUND AND OBJECTIVE: Cisplatin is the first-line drug for the chemotherapy of non-small cell lung cancer (NSCLC), but the acquired chemoresistance restricted the effect of its treatment. The aim of this study is to validate the miRNAs related to the Cisplatin resistance in lung cancer and eluci...
Сохранить в:
| Опубликовано в: : | Zhongguo Fei Ai Za Zhi |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
中国肺癌杂志编辑部
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000442/ https://ncbi.nlm.nih.gov/pubmed/24854555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.04 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|